89bio Inc
General ticker "ETNB" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $884.7M
89bio Inc does not follow the US Stock Market performance with the rate: -15.1%.
Estimated limits based on current volatility of 5.8%: low 7.19$, high 8.08$
Factors to consider:
- Company does not operate outside North America (retrieved using AI)
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [5.17$, 12.13$]
- 2024-12-30 to 2025-12-30 estimated range: [3.29$, 8.14$]
Financial Metrics affecting the ETNB estimates:
- Negative: Non-GAAP EPS, $ of -2.01 <= 0.10
- Negative: Operating profit margin, % of -100 <= 1.03
- Negative: negative Net income
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
- Negative: Operating cash flow per share per price, % of -15.72 <= 2.35
Short-term ETNB quotes
Long-term ETNB plot with estimates
Financial data
YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|
Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
Operating Expenses | $89.74MM | $102.25MM | $151.20MM |
Operating Income | $-89.74MM | $-102.25MM | $-151.20MM |
Non-Operating Income | $-0.53MM | $0.24MM | $12.88MM |
Interest Expense | $0.67MM | $1.92MM | $3.59MM |
R&D Expense | $70.33MM | $80.80MM | $122.23MM |
Income(Loss) | $-90.27MM | $-102.01MM | $-138.32MM |
Taxes | $-0.15MM | $0.02MM | $3.87MM |
Profit(Loss) | $-90.12MM | $-102.03MM | $-142.19MM |
Stockholders Equity | $125.96MM | $151.83MM | $536.31MM |
Assets | $162.42MM | $196.82MM | $596.27MM |
Operating Cash Flow | $-76.78MM | $-81.09MM | $-129.19MM |
Capital expenditure | $0.06MM | $0.01MM | $0.00MM |
Investing Cash Flow | $7.16MM | $-33.94MM | $-123.02MM |
Financing Cash Flow | $23.87MM | $117.83MM | $513.11MM |
Earnings Per Share* | $-4.48 | $-2.93 | $-2.00 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.